FDA Reclassifies Peptides: Clinical Implications and Consequences Nikhil Verma M.D. posted on the topic LinkedIn The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA to weigh lifting restrictions on some MAHA favored peptides BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn